Results showed an increased risk of bleeding with SRIs by 1.16-2.36 times with an even higher 3.17- to 10.9-fold. risk with concomitant NSAIDs.
Depression is common in patients with axSpA and is associated with more severe disease activity and functional impairment.
These data suggest that marijuana use, particularly non-medical use, is associated with poorer depression and anxiety outcomes in psychiatric patients.
These data suggest a neurologic basis for the relationship between sleep quality and depressive symptoms, even among patients with no clinical diagnosis of depression.
One of the main reasons for the frequent misdiagnosis of catatonia is the continuing misconception that it is synonymous with schizophrenia.
The rate of suicide attempts in participants assigned to intervention plus treatment as usual was half of that in participants in the treatment as usual-alone group.
Marijuana usage is increasing in adolescents, and the rate of comorbidity with mood and anxiety disorders is high. These findings may aid in identifying adolescents who are potentially at risk.
Depression is associated with poorer outcomes in ACS and these findings suggest that this course of treatment may improve long-term major adverse cardiac event outcomes.
Investigators examined traits which may predispose to violence in patients with schizophrenia, including psychopathic and impulsive traits along with aggression traits.
Incidence of depression occurred mostly within the first 2 years after parental death in patients whose parent died at the age of 12 or younger.
The findings support second generation long-acting injectable antipsychotic drug use as early treatment option to increase treatment adherence and to decrease the risk of relapse, hospitalization, and deteriorating social functions.
These data substantiate claims that certain neuroinflammatory biomarkers may predict depression symptoms or severity and could be useful in developing diagnostic and treatment strategies.
A lower socioeconomic status, childhood maltreatment, and the presence of comorbid mental health conditions were associated with diagnosed OCD in the studied Canadian population.
The potential consequences of providing cosmetic treatment to a patient with BDD can extend beyond ethical concerns.
There is no distinct cut off for the Functional Assessment Short Test between none, mind, moderate, and severe functional impairment.